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The two sides of Tat
A virus protein called Tat plays a dual role in HIV infection by regulating
the expression of genes belonging to the virus and genes belonging to
the host cells.
MATJAZ BARBORIC AND KOH FUJINAGA
L
ike all viruses, human immunodeficiency
virus (HIV) must engage with the cells of
its host to be able to replicate. Compared
to other retroviruses, this interaction is particu-
larly complex in the case of HIV because its
genome encodes many proteins that take advan-
tage of various cell processes and counteract
host defenses. One of these proteins is called
transactivator of transcription (Tat) and it is
essential for the expression of HIV genes in host
cells. Now, in eLife, Ivan D’Orso of the University
of Texas Southwestern Medical Center (UTSW)
and colleagues – including Jonathan Reeder and
Youn-Tae Kwak of UTSW as joint first authors –
demonstrate that Tat can also regulate the
expression of many host genes (Reeder et al.,
2015).
In the first stage of gene expression, a gene
is “transcribed” to make messenger RNA
(mRNA) by an enzyme called RNA polymerase II
(Pol II). After Pol II binds to the promoter region
of a gene and starts to make an mRNA mole-
cule, the enzyme stops due to the actions of
pause-inducing factors. The ability of Pol II to
continue to transcribe the gene (in a step called
elongation) depends on a cellular
protein complex called P-TEFb (short for posi-
tive transcription elongation factor b). In the
case of HIV, the situation is very similar. Pol II
pauses soon after initiating from the promoter
of the viral genome producing only short
mRNAs. However, Tat can override this tran-
scriptional block by recruiting P-TEFb to Pol II
via a RNA stem-loop structure called the trans-
activation response element, which is found at
the beginning of all virus mRNAs (Ott et al.,
2011).
While most researchers have focused on
understanding how Tat activates the transcrip-
tion of HIV, some studies have demonstrated
that Tat also alters the expression of host genes
to promote the production and spread of HIV.
For example, Tat manipulates immune T cells in
its host to allow the virus to infect and replicate
in them (Li et al., 1997, Huang et al., 1998).
Moreover, Tat induces the expression of chemo-
kines that attract uninfected T cells and macro-
phages, facilitating expansion of HIV in the host
(Izmailova et al., 2003). On the other side, Tat
can also contribute to the depletion of T cells
during AIDS progression by up-regulating cellu-
lar pro-apoptotic genes (Kim et al., 2010).
Finally, Tat is able to repress the transcription of
several genes encoding receptors of the innate
immune system responses. However, we still do
not have a comprehensive view of the host
genes that Tat targets, or how Tat alters the
transcription of these genes.
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Reeder, Kwak, D’Orso and two colleagues –
Ryan McNamara (UTSW) and Christian Forst
(Icahn School of Medicine at Mount Sinai) – took
on this challenge by analyzing T cells that pro-
duced the Tat protein with a series of genome-
wide approaches. They identified close to 3000
sites in the human genome that are occupied by
Tat. The presence of Tat changed the expression
of about 2000 host genes, and almost quarter of
these were classified as direct targets because
Tat bound to their promoters or to other sites in
the genes. About half of these direct targets
were up-regulated by Tat, while the rest were
down-regulated. Further experiments revealed
that for a subset of the target genes, Tat is able
to regulate either the initiation or elongation by
Pol II.
Next, Reeder, Kwak et al. investigated how
Tat can modulate different steps in the transcrip-
tion of host genes. For example, to stimulate or
inhibit the start of transcription, Tat regulates
the loading Pol II to cellular promoters. Of note,
at the majority of up-regulated genes, Tat
appears to facilitate Pol II promoter presence
from sites within gene bodies by inducing DNA
looping. However, to regulate elongation, Tat
can either promote or prevent the recruitment
of P-TEFb to specific genes. Importantly,
Reeder, Kwak et al.’s further findings suggest
that, unlike what happens with viral genes, Tat
does not seem to rely on RNA structures similar
to the HIV transactivation response element to
regulate target host genes. Instead, Tat co-opts
some of the master transcriptional regulators of
its host that also control cellular gene transcrip-
tion in uninfected cells.
In agreement with an earlier report
(Marban et al., 2011), Reeder, Kwak et al. found
that binding sites for the master regulator called
ETS1 were, among others, most frequent near
the genomic regions that Tat occupies. Tat inter-
acts with ETS1 protein and knocking down the
ETS1 gene abolished the recruitment of Tat to
some target genes, thus preventing it from
being able to modulate their transcription.
Moreover, ETS1 motifs are found at both up-
regulated and down-regulated Tat targets,
underscoring that gene-specific circumstances
determine the effect of Tat. Curiously, HIV itself
contains an ETS1 binding site upstream of its
promoter, and this allows ETS1 to stimulate viral
gene expression in collaboration with other tran-
scription factors of the cell (Sieweke et al.,
1998; Yang et al., 2009).
The report by Reeder, Kwak et al. arguably
represents the most thorough characterization
of the role of Tat on host gene expression. While
making sure that the HIV genome is transcribed,
Tat also fine-tunes two critical steps in the
expression of specific cellular genes. Is this
tweaking of host gene transcription a necessary
survival strategy for HIV, or merely a side effect
of the presence of potent transcriptional regula-
tor Tat in the cell nucleus? Or has this possible
side effect been transformed through evolution
into a winning strategy of the virus? Whatever
the correct answer might be, Reeder, Kwak
et al. confirmed that the expression of many Tat
target genes changed as expected during HIV
infection. Moreover, many of these genes
appear to be involved in signaling pathways and
biological processes that could help HIV to
spread in the host.
This study raises further questions. Does Tat
modulate the expression of hundreds of previ-
ously identified host proteins that interact with
HIV gene products or are critical to replication
of the virus? Is Tat also capable of regulating the
termination of transcription at host genes? How
exactly do the interactions between Tat, master
transcriptional regulators like ETS1, and host
proteins lead to changes in gene expression?
Further, has HIV devised one strategy to pro-
mote very high levels of transcription of its own
genome, while exploiting cellular transcriptional
regulators to provoke only modest (but benefi-
cial) changes in the expression of host genes?
Answers to these and other questions shall
advance our understanding of how and why HIV
Tat reprograms its host.
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